CVRx outlines $63M-$67M 2026 revenue target as Barostim adoption accelerates with new CPT code
Source: SeekingAlpha
2026-02-12 22:15:11 ET
More on CVRx
- CVRx, Inc. (CVRX) Q4 2025 Earnings Call Transcript
- CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- CVRx reports preliminary 2025 results, issues 2026 guidance
- Seeking Alpha’s Quant Rating on CVRx
Read the full article on Seeking Alpha
For further details see:
CVRx outlines $63M-$67M 2026 revenue target as Barostim adoption accelerates with new CPT code
CVRx Inc.
NASDAQ: CVRX
CVRX Trading
-4.0% G/L:
$7.79 Last:
118,990 Volume:
$8.13 Open:
CVRX Latest News
March 02, 2026 08:30:00 am
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
February 12, 2026 04:05:00 pm
CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
CVRX Stock Data
$174,952,478
20,522,515
15.36%
28
N/A
Medical Equipment & Supplies
Healthcare
US
Minneapolis
